SI3066097T1 - Soli 1-(3-metil-2-okso-2,3-dihidro-1,3-benzoksazol-6-il)-2,4-diokso-3-((1r)-4 -(trifluormetil)-2,3-dihidro-1H-inden-1-il)-1,2,3,4-tetrahidropirimidin- 5-ogljikove kisline - Google Patents
Soli 1-(3-metil-2-okso-2,3-dihidro-1,3-benzoksazol-6-il)-2,4-diokso-3-((1r)-4 -(trifluormetil)-2,3-dihidro-1H-inden-1-il)-1,2,3,4-tetrahidropirimidin- 5-ogljikove kislineInfo
- Publication number
- SI3066097T1 SI3066097T1 SI201430450T SI201430450T SI3066097T1 SI 3066097 T1 SI3066097 T1 SI 3066097T1 SI 201430450 T SI201430450 T SI 201430450T SI 201430450 T SI201430450 T SI 201430450T SI 3066097 T1 SI3066097 T1 SI 3066097T1
- Authority
- SI
- Slovenia
- Prior art keywords
- dihydro
- tetrahydropyrimidin
- trifluormethyl
- benzoxazol
- inden
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13192177 | 2013-11-08 | ||
| PCT/EP2014/073801 WO2015067652A1 (de) | 2013-11-08 | 2014-11-05 | Salze von 1 -(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)-2,4-dioxo-3-[(1 r)-4-(trifluormethyl)-2,3-dihydro-1h-inden-1 -yl]-1,2,3,4-tetrahydropyrimidin-5-carbonsäure |
| EP14793565.4A EP3066097B1 (de) | 2013-11-08 | 2014-11-05 | Salze von 1-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)-2,4-dioxo-3-[(1r)-4-(trifluormethyl)-2,3-dihydro-1h-inden-1-yl]-1,2,3,4-tetrahydropyrimidin-5-carbonsäure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3066097T1 true SI3066097T1 (sl) | 2017-12-29 |
Family
ID=49552231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201430450T SI3066097T1 (sl) | 2013-11-08 | 2014-11-05 | Soli 1-(3-metil-2-okso-2,3-dihidro-1,3-benzoksazol-6-il)-2,4-diokso-3-((1r)-4 -(trifluormetil)-2,3-dihidro-1H-inden-1-il)-1,2,3,4-tetrahidropirimidin- 5-ogljikove kisline |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US9926305B2 (https=) |
| EP (1) | EP3066097B1 (https=) |
| JP (1) | JP6446051B2 (https=) |
| KR (1) | KR102351418B1 (https=) |
| CN (1) | CN105658647B (https=) |
| AP (1) | AP2016009181A0 (https=) |
| AU (1) | AU2014345599B2 (https=) |
| BR (1) | BR112016010253A8 (https=) |
| CA (1) | CA2929780C (https=) |
| CL (1) | CL2016001096A1 (https=) |
| CY (1) | CY1119520T1 (https=) |
| DK (1) | DK3066097T3 (https=) |
| EA (1) | EA033132B1 (https=) |
| ES (1) | ES2645480T3 (https=) |
| HR (1) | HRP20171603T1 (https=) |
| HU (1) | HUE035021T2 (https=) |
| IL (1) | IL245407B (https=) |
| LT (1) | LT3066097T (https=) |
| MA (1) | MA39020A1 (https=) |
| ME (1) | ME02907B (https=) |
| MX (1) | MX366848B (https=) |
| MY (1) | MY190108A (https=) |
| NO (1) | NO3066097T3 (https=) |
| PH (1) | PH12016500853B1 (https=) |
| PL (1) | PL3066097T3 (https=) |
| PT (1) | PT3066097T (https=) |
| RS (1) | RS56509B1 (https=) |
| SA (1) | SA516371082B1 (https=) |
| SI (1) | SI3066097T1 (https=) |
| TN (1) | TN2016000170A1 (https=) |
| UA (1) | UA117686C2 (https=) |
| WO (1) | WO2015067652A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3338780A1 (de) | 2016-12-20 | 2018-06-27 | Bayer Pharma Aktiengesellschaft | Verwendung von chymaseinhibitoren zur behandlung von endometriose, post-operativer fibrose und erkrankungen die durch fibrosebildung gekennzeichnet sind |
| WO2018197333A1 (en) * | 2017-04-27 | 2018-11-01 | Bayer Aktiengesellschaft | Selective adrenoreceptor alpha2c receptor antagonists alone, or in combination with chymase inhibitors for use in the treatment and/or prophylaxis of peripheral artery diseases (pad) |
| CN114671856B (zh) * | 2020-12-25 | 2023-10-20 | 广东东阳光药业股份有限公司 | 多取代的尿嘧啶衍生物及其用途 |
| CA3255475A1 (en) * | 2022-04-05 | 2023-10-12 | Socpra Sciences Santé Et Humaines S.E.C. | CHYMASE INHIBITORS INTENDED FOR USE IN THE SELECTIVE RESOLUTION OF THROMBUS IN THROMBOTIC OR THROMBOEMBOLIC DISORDERS |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001295952A1 (en) * | 2000-10-19 | 2002-04-29 | Nippon Kayaku Kabushiki Kaisha | Novel remedies or preventives for angiostenosis |
| AT511788A1 (de) | 2011-07-29 | 2013-02-15 | Georg Dr Gaul | Vorrichtung zur vorgebbaren anordnung eines stents |
| CA2866184A1 (en) * | 2012-03-05 | 2013-09-12 | Gratuk Technologies Pty Ltd | Dietary supplement |
| UA112897C2 (uk) * | 2012-05-09 | 2016-11-10 | Байєр Фарма Акцієнгезелльшафт | Біциклічно заміщені урацили та їх застосування для лікування і/або профілактики захворювань |
| EP3066096A1 (de) * | 2013-11-08 | 2016-09-14 | Bayer Pharma Aktiengesellschaft | Substituierte uracile als chymase inhibitoren |
-
2014
- 2014-11-05 AP AP2016009181A patent/AP2016009181A0/en unknown
- 2014-11-05 MX MX2016005971A patent/MX366848B/es active IP Right Grant
- 2014-11-05 EP EP14793565.4A patent/EP3066097B1/de active Active
- 2014-11-05 PL PL14793565T patent/PL3066097T3/pl unknown
- 2014-11-05 CA CA2929780A patent/CA2929780C/en active Active
- 2014-11-05 EA EA201600381A patent/EA033132B1/ru not_active IP Right Cessation
- 2014-11-05 HU HUE14793565A patent/HUE035021T2/en unknown
- 2014-11-05 JP JP2016551038A patent/JP6446051B2/ja active Active
- 2014-11-05 MY MYPI2016701615A patent/MY190108A/en unknown
- 2014-11-05 TN TN2016000170A patent/TN2016000170A1/en unknown
- 2014-11-05 AU AU2014345599A patent/AU2014345599B2/en active Active
- 2014-11-05 LT LTEP14793565.4T patent/LT3066097T/lt unknown
- 2014-11-05 US US15/035,165 patent/US9926305B2/en active Active
- 2014-11-05 WO PCT/EP2014/073801 patent/WO2015067652A1/de not_active Ceased
- 2014-11-05 UA UAA201606202A patent/UA117686C2/uk unknown
- 2014-11-05 CN CN201480057947.4A patent/CN105658647B/zh active Active
- 2014-11-05 RS RS20171063A patent/RS56509B1/sr unknown
- 2014-11-05 KR KR1020167011771A patent/KR102351418B1/ko active Active
- 2014-11-05 MA MA39020A patent/MA39020A1/fr unknown
- 2014-11-05 DK DK14793565.4T patent/DK3066097T3/da active
- 2014-11-05 ME MEP-2017-249A patent/ME02907B/me unknown
- 2014-11-05 ES ES14793565.4T patent/ES2645480T3/es active Active
- 2014-11-05 NO NO14793565A patent/NO3066097T3/no unknown
- 2014-11-05 SI SI201430450T patent/SI3066097T1/sl unknown
- 2014-11-05 HR HRP20171603TT patent/HRP20171603T1/hr unknown
- 2014-11-05 PT PT147935654T patent/PT3066097T/pt unknown
- 2014-11-05 BR BR112016010253A patent/BR112016010253A8/pt not_active Application Discontinuation
-
2016
- 2016-05-01 IL IL24540716A patent/IL245407B/en active IP Right Grant
- 2016-05-06 CL CL2016001096A patent/CL2016001096A1/es unknown
- 2016-05-06 PH PH12016500853A patent/PH12016500853B1/en unknown
- 2016-05-08 SA SA516371082A patent/SA516371082B1/ar unknown
-
2017
- 2017-10-25 CY CY20171101110T patent/CY1119520T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285971A (en) | Pyrimidinedione compounds against cardiac conditions | |
| MA40551A (fr) | Composés actifs envers des bromodomaines | |
| SG10201912070VA (en) | Toothbrush system with magnetometer for dental hygiene monitoring | |
| EP2928400A4 (en) | ELECTRO-SURGICAL HAND TOOL | |
| MA41272A (fr) | 5-fluoro-4-imino-3-(alkyle/alkyle substitué)-1-(arylsulfonyl)-3,4-dihydropyrimidin-2(1h)-one en tant que traitement des semences | |
| EP3698755C0 (en) | FILAMENT MANAGEMENT DEVICE | |
| PL3431035T3 (pl) | Instrument do opracowywania kanałów korzeni zębowych | |
| BR112016013502A2 (pt) | unidade de dosagem sólida que desintegra oralmente contendo um componente de estetrol. | |
| HRP20160250T1 (hr) | Postupak za pripravu 2-(2,3-dimetilfenil)-1-propanala s kloracetonom | |
| SG11201703356TA (en) | Management of medication preparation with dynamic processing | |
| GB201322237D0 (en) | Surgical reamer | |
| DK3310333T3 (da) | Oralt dispergibel doseringsenhed indeholdende en estetrolkomponent | |
| PL3256464T3 (pl) | Związki mające aktywność antagonisty receptora muskarynowego i agonisty receptora beta2 adrenergicznego<div> </div> | |
| IL243403B (en) | Treatment for seeds disinfection | |
| IL251379B (en) | Compositions for oral care containing zinc, arginine and serine | |
| EP3148500A4 (en) | Oral care compositions having improved stability | |
| CL2017001467A1 (es) | Compuestos de dihidropirimidin - 2 - ona y sus usos médicos | |
| BR112017013012A2 (pt) | compostos de indenil, composições farmacêuticas e usos médicos destes | |
| SI3066097T1 (sl) | Soli 1-(3-metil-2-okso-2,3-dihidro-1,3-benzoksazol-6-il)-2,4-diokso-3-((1r)-4 -(trifluormetil)-2,3-dihidro-1H-inden-1-il)-1,2,3,4-tetrahidropirimidin- 5-ogljikove kisline | |
| HUE055559T2 (hu) | Menetes fogászati implantátum | |
| IL254578A0 (en) | Abscisic acid (s)-2' vinyl derivatives | |
| IL256719B (en) | Oral care compositions | |
| HUE071186T2 (hu) | Trazodon és gabapentin kombinációja fájdalom kezelésére | |
| LT3217998T (lt) | Kompozicijos, turinčios apoekvorino, skirtos naudoti neuroninių ląstelių žūties nuo išemijos gydymo būde, įvedant jas peroraliai | |
| BR112017007638A2 (pt) | composições de higiene bucal que compreendem compostos de zinco e compostos de peróxido |